ADAMTS2 Protein Emerges as a Key Player in Future Therapies

Image Caption: Schematic representation of the exon (A) and protein domain (B) structure of ADAMTS2. Credit Genes & Diseases

ADAMTS2, a member of the ADAMTS (A Disintegrin And Metalloproteinase with Thrombospondin motifs) family of zinc metalloproteinases, has long been recognized for its critical role in connective tissue biology. Traditionally, this enzyme has been studied as a procollagen I N-proteinase, responsible for processing type I procollagen molecules into mature fibrillar collagens. These fibrillar collagens are fundamental building blocks of connective tissue, ensuring the strength, elasticity, and stability of skin, tendons, ligaments, and other supportive structures in the body.

For many years, the primary focus of ADAMTS2 research centered on collagen maturation. However, recent studies have dramatically broadened our understanding of this enzyme, revealing that its functions extend well beyond collagen processing. Today, ADAMTS2 is increasingly recognized as a multifunctional protein with diverse biological roles in areas such as angiogenesis, neurodevelopment, immune regulation, and cardiovascular health. These discoveries are opening new avenues for its potential as both a biomarker and a therapeutic target in a wide range of diseases.

ADAMTS2 and Genetic Disorders

One of the most important breakthroughs in ADAMTS2 research has been its association with dermatosparaxis type Ehlers-Danlos syndrome (dEDS), a rare but severe genetic disorder. Patients with dEDS suffer from extreme skin fragility due to defective collagen processing. At the molecular level, the absence or dysfunction of ADAMTS2 leads to the retention of N-propeptides in type I procollagen molecules. This defect prevents proper fibril formation, resulting in collagen that is weak, irregular, and unable to support normal tissue structure.

This discovery not only clarified the molecular basis of dEDS but also underscored the indispensable role of ADAMTS2 in collagen homeostasis. Without its enzymatic activity, the structural framework of connective tissues is compromised, leading to profound clinical consequences.

READ ALSO: “Rising Threats in Antarctica Highlight Urgent Need for Global Action”

READ ALSO: ‘Surface Avatar’ Robot Test Wraps Up on ISS, Bringing Mars Missions Closer

Beyond Collagen: Roles in Angiogenesis and Cancer

Research has shown that ADAMTS2 is not limited to connective tissue regulation. It also plays an important role in angiogenesis, the process by which new blood vessels form. Interestingly, ADAMTS2 demonstrates anti-angiogenic and anti-tumorigenic properties. By binding to nucleolin on the surface of endothelial cells, it interferes with cell proliferation, alters cell morphology, and promotes a form of programmed cell death known as anoikis.

These anti-angiogenic functions mean that ADAMTS2 can suppress tumor growth and metastasis by limiting the supply of blood vessels that feed tumors. As a result, ADAMTS2 is emerging as a potential therapeutic target in oncology, where controlling blood vessel formation is a key strategy for cancer treatment.

Role in Lymphatic System Regulation

Another fascinating discovery involves ADAMTS2’s contribution to lymphangiogenesis, the formation of lymphatic vessels. The enzyme activates VEGFC, a growth factor crucial for lymphatic vessel development, by processing it into its active form. This activation promotes signaling through VEGFR3, a receptor essential for lymphatic growth and maintenance.

Through this mechanism, ADAMTS2 helps maintain lymphatic homeostasis and may be particularly relevant in diseases where lymphangiogenesis plays a role, such as lymphedema, chronic inflammation, or even cancer metastasis through lymphatic spread.

Impact on the Nervous System

ADAMTS2 also plays a surprisingly important role in the brain. It has been shown to interact with Reelin, a glycoprotein critical for neuronal migration, synaptic function, and overall neurodevelopment. When ADAMTS2 cleaves Reelin, the result can be impaired neuronal signaling and migration.

Disruptions in Reelin activity have been linked to neurodegenerative and neuropsychiatric conditions, including Alzheimer’s disease and schizophrenia. This connection positions ADAMTS2 as a protein of interest in the study of brain disorders, suggesting that modulating its activity could one day help address certain neurological pathologies.

READ ALSO: Merlin Partners with Northrop Grumman to Advance Next-Generation Autonomous Flight

READ ALSO: Hyundai Motor, Kia and Samsung SDI Collaborate to Develop High-Performance Robot Batteries

Immune and Cardiovascular Functions

The influence of ADAMTS2 extends further into the immune system. It affects the activity of immune components such as immunoglobulins, complement proteins, and macrophage inhibitory factors. By shaping these pathways, ADAMTS2 may act as an immune modulator, influencing both inflammation and immune defense mechanisms.

In the cardiovascular system, ADAMTS2 has been implicated in cardiac hypertrophy and heart failure. Through its interactions with the PI3K/AKT signaling pathway, ADAMTS2 appears to regulate responses to cardiac stress, offering a potential cardioprotective function. This raises intriguing possibilities for targeting ADAMTS2 in the management of heart disease.

A Promising Therapeutic Target

The growing body of evidence demonstrates that ADAMTS2 is much more than a collagen-processing enzyme. Its diverse roles—in genetic disorders, angiogenesis, lymphatic regulation, neurodevelopment, immune balance, and cardiovascular health—highlight its potential as a multifunctional therapeutic target.

Future research focused on understanding the regulation of ADAMTS2, its interactions with other proteins, and the downstream effects of its activity could pave the way for novel therapeutic interventions. Targeted modulation of ADAMTS2 activity may offer new treatments not only for rare genetic conditions like dEDS but also for widespread diseases such as cancer, cardiovascular disease, and neurodegenerative disorders.

As science continues to unravel the complexities of this remarkable protein, ADAMTS2 is poised to move from a specialized collagen enzyme to a central player in human health and disease, offering hope for innovative therapies in the years ahead.